Nkarta Inc (NASDAQ: NKTX) stock jumped 0.19% on Monday to $2.62 against a previous-day closing price of $2.61. With 0.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.52 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.6500 whereas the lowest price it dropped to was $2.4900. The 52-week range on NKTX shows that it touched its highest point at $9.91 and its lowest point at $1.28 during that stretch. It currently has a 1-year price target of $14.12. Beta for the stock currently stands at 0.10.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NKTX was up-trending over the past week, with a rise of 36.91%, but this was up by 18.86% over a month. Three-month performance surged to 47.74% while six-month performance fell -40.70%. The stock lost -72.96% in the past year, while it has lost -56.34% so far this year. A look at the trailing 12-month EPS for NKTX yields -2.50 with Next year EPS estimates of -2.33. For the next quarter, that number is -0.59. This implies an EPS growth rate of 7.55% for this year and 3.63% for next year.
Float and Shares Shorts:
At present, 48.88 million NKTX shares are outstanding with a float of 37.50 million shares on hand for trading. On Oct 30, 2023, short shares totaled 6.94 million, which was 14.14% higher than short shares on Sep 28, 2023. In addition to Mr. Paul J. Hastings as the firm’s CEO, President & Director, Dr. Alicia J. Hager serves as its Chief Legal Officer & Corporate Secretary.
Institutional Ownership:
Through their ownership of 88.18% of NKTX’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NKTX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With NKTX analysts setting a high price target of $25.00 and a low target of $9.00, the average target price over the next 12 months is $14.13. Based on these targets, NKTX could surge 854.2% to reach the target high and rise by 243.51% to reach the target low. Reaching the average price target will result in a growth of 439.31% from current levels.
Summary of Insider Activity:
Insiders traded NKTX stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 1,331 shares were sold. The number of buy transactions has increased to 6 while that of sell transactions has risen to 13 over the past year. The total number of shares bought during that period was 235,500 while 13,058 shares were sold.
